Overall rank by patents
#42,428
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Powder Pharmaceuticals Incorporated
USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
6
Total patents granted
4
CPC technology areas
14.5
Avg claims per patent
-100%
5-year filing velocity
The verdict
Powder holds 6 US patents across 4 technology areas, rank #42,428 of 50,000 tracked assignees.
- #42,428
- of 50,000 US assignees by volume
- Top 90%
- by Innovation Score (22.5/100)
- 14.5
- avg claims per patent
- -100%
- filing velocity, last 5 yrs
Portfolio overview
Powder Pharmaceuticals Incorporated has been granted 6 US utility patents between 2015 and 2019, placing Powder Pharmaceuticals Incorporated at rank #42,428 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.5 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Powder Pharmaceuticals Incorporated is one of the more focused assignees in the PatentsView dataset. By volume, Powder sits between Polyganics IP B.v. (6 patents, rank #42,424) and Preco Electronics, Llc (6 patents, rank #42,432) - the closest US assignees by grant volume. The composite Innovation Score of 22.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 6 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Powder Pharmaceuticals Incorporated's 14.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Powder Pharmaceuticals Incorporated against peers pursuing similar technology classes.
Who files at Powder's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Polyganics IP B V
Polyganics IP B.V.
6 patents
- Popdust
Popdust, Inc.
6 patents
- Popular Metrics
Popular Metrics, Inc.
6 patents
- Porta-fab
Porta-Fab Corporation
6 patents
- Power Survey
Power Survey LLC
6 patents
- Praxis Powder Tec…
Praxis Powder Technology, Inc.
6 patents
- Precis
Precis, LLC
6 patents
- Preco
Preco Electronics, LLC
6 patents
- Powder Pharmaceut… ◀
Powder Pharmaceuticals Incorporated
6 patents
What this shows Powder holds 6 patents at rank #42,428, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Powder
By rank, the assignees closest to #42,428 in granted patent volume.
- Polyganics IP B.v. #42,424 · 6 patents
- Popdust, Inc. #42,425 · 6 patents
- Popular Metrics, Inc. #42,426 · 6 patents
- Porta-fab Corporation #42,427 · 6 patents
- Power Survey Llc #42,429 · 6 patents
- Praxis Powder Technology, Inc. #42,430 · 6 patents
- Precis, Llc #42,431 · 6 patents
- Preco Electronics, Llc #42,432 · 6 patents
Leaders in A61M (Devices FOR Introducing Media INTO)
Other assignees with the most granted patents in Powder's primary technology class.
- Becton, Dickinson And Company 1,249 in class
- Sanofi-aventis Deutschland Gmbh 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.v. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien Lp 726 in class
- Terumo Kabushiki Kaisha 724 in class
- Resmed Pty Ltd 682 in class
Powder's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
22 Top 90% higher than 10% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 2 | 33.3% |
| 2018 | 1 | 16.7% |
| 2019 | 2 | 33.3% |
Which technologies does Powder Pharmaceuticals Incorporated patent most?
Top 4 of 4 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Powder Pharmaceuticals Incorporated hold?
Powder Pharmaceuticals Incorporated holds 6 US granted patents filed between 2015 and 2019, spanning 4 technology areas.
What is Powder Pharmaceuticals Incorporated's Innovation Score?
Powder Pharmaceuticals Incorporated has an Innovation Score of 22.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Powder Pharmaceuticals Incorporated focus on?
Powder Pharmaceuticals Incorporated's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 6 patents. The company has filed patents in 4 CPC subclasses total.
Is Powder Pharmaceuticals Incorporated's patent filing rate increasing or decreasing?
Powder Pharmaceuticals Incorporated's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Powder Pharmaceuticals Incorporated's patents?
Powder Pharmaceuticals Incorporated's patents average 14.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Powder Pharmaceuticals Incorporated patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Powder's 6 grants land it in the top 90% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Powder ranks #42,428 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.